A phase I clinical trial of VS 4718 in healthy volunteers.
Latest Information Update: 16 Jul 2012
Price :
$35 *
At a glance
- Drugs VS 4718 (Primary)
- Indications Cancer
- Focus Therapeutic Use
- Sponsors Verastem Oncology
- 16 Jul 2012 New trial record
Latest Information Update: 16 Jul 2012